Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes

Vaccine

Volumn 28, Issue 4, 2010, Pages 1002-1007

  Kakoulidou, Maria ^a,b   Forsgren, Marianne ^c   Lewensohn Fuchs, Ilona ^c   Johansen, Kari ^a,b,d  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Antenatal; IgG antibody; Immunological memory; Post partum; Pregnant women; Rubella; Vaccination

Indexed keywords

IMMUNOGLOBULIN G; MEASLES MUMPS RUBELLA VACCINE; RUBELLA ANTIBODY; RUBELLA VACCINE;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RUBELLA; SCHOOL CHILD; SCREENING TEST; SWEDEN; VACCINATION;

ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; EMIGRANTS AND IMMIGRANTS; FEMALE; GEOGRAPHY; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; SERUM; SWEDEN;

EID: 74249112395     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.130     Document Type: Article

References (19)

1. Plotkin S., and Reef S. Rubella vaccine. 5th ed. (2008), WB Saunders Co., London
2. Forsgren M., Barr B., Böttiger M., Eriksson M., Grillner L., Hirsch A., et al. Vaccination against rubella in Sweden-a follow-up. Läkartidningen 83 13 (1986) 1170-1173
3. Grillner L., Hedström C.E., Bergström H., Forssman L., Rigner A., and Lycke E. Vaccination against rubella of newly delivered women. Scand J Infect Dis 5 4 (1973) 237-241
4. Böttiger M., and Forsgren M. Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination. Vaccine 15 14 (1997) 1538-1544
5. Grillner L., Forsgren M., Barr B., Böttiger M., Danielsson L., and De Verdier C. Outcome of rubella during pregnancy with special reference to the 17th-24th weeks of gestation. Scand J Infect Dis 15 4 (1983) 321-325
6. http://www.smittskyddsinstitutet.se, Swedish Institute for Infectious Disease Control; 2007.
7. Aboudy Y., Barnea B., Yosef L., Frank T., and Mendelson E. Clinical rubella reinfection during pregnancy in a previously vaccinated woman. J Infect 41 2 (2000) 187-189
8. Aboudy Y., Fogel A., Barnea B., Mendelson E., Yosef L., Frank T., et al. Subclinical rubella reinfection during pregnancy followed by transmission of virus to the fetus. J Infect 34 3 (1997) 273-276
9. Best J.M. Rubella. Semin Fetal Neonatal Med 12 3 (2007) 182-192
10. Best J.M., Banatvala J.E., Morgan-Capner P., and Miller E. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. Br Med J 299 6702 (1989) 773-775
11. Forsgren M., and Sörén L. Subclinical rubella reinfection in vaccinated women with rubella-specific IgM response during pregnancy and transmission of virus to the fetus. Scand J Infect Dis 17 4 (1985) 337-341
12. Davidkin I., Peltola H., Leinikki P., and Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine 18 27 (2000) 3106-3112
13. Nardone A., Tischer A., Andrews N., Backhouse J., Theeten H., Gatcheva N., et al. Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. WHO 86 2 (2008) 118-125
14. Davidkin I., Jokinen S., Broman M., Leinikki P., and Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 197 7 (2008) 950-956
15. Skendzel L.P. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 106 2 (1996) 170-174
16. WHO. Strategic plan for measles and congenital rubella infection in the European region of WHO (2003), WHO Regional Office for Europe, Copenhagen, Denmark
17. Olin P., Carlsson R.M., Johansen K., Hallander H., Ljungman M., Svensson A., et al. Vaccination follow-up. Sero epidemiological cross-sectional study 1997 (2006). http://www.smittskyddsinstitutet.se/publikationer/smis-rapportserie/ar-2 004/vaccinationsuppfoljning-seroepidemiologisk-tvarsnittsstudie-1997-slu trapport-3-2004 http://www.smittskyddsinstitutet.se/publikationer/smis-rapportserie/ar-2 004/vaccinationsuppfoljning-seroepidemiologisk-tvarsnittsstudie-1997-slu trapport-3-2004
18. Johansen K., Sjödin M., Westrell-Oskarsson L., Arneborn M., Åkerlind B., and Forsgren M. [Rubella still a problem in Europe-important that pregnant women have an adequate protection]. Läkartidningen 101 49 (2004) 3994-3996, 98-99
19. http://www.skolverket.se [Comparative data concerning pre-school care, health care for school child, school and adult education]; 2008.